In the wake of the COVID-19 pandemic, the intricate dance between patent rights and public health has taken center stage. This groundbreaking book navigates this complex terrain, probing the nuances of intellectual property rights amidst a global health crisis. From dissecting the impact of TRIPS agreements to scrutinizing the efficacy of compulsory licensing, it unveils the stark disparities in access to life-saving medicines. Through meticulous analysis and bold recommendations, it advocates for a paradigm shift in the intellectual property regime, emphasizing the imperative of prioritizing human life over profit. A rallying cry for change, this book is essential reading for policymakers, healthcare professionals, and anyone committed to forging a more equitable future in the face of adversity.